Back to calendar
SAB Biotherapeutics, Inc. (SABS) Earnings
SABS reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · Before Market Open
Est. EPS: $-0.28
Actual EPS: $-0.35
EPS surprise: -64.73%
Company overview
Market Cap$275.3M
PriceUSD 3.60
EPS (TTM)-2.47
52-week high6.60
52-week low1.85
SectorHealth Technology
IndustryBiotechnology
Employees86